✦ LIBER ✦
1182 CHARACTERIZATION OF HCV NS3 PROTEASE VARIANTS FROM PATIENTS ENROLLED IN A 28-DAY PHASE 2A TRIAL OF ACH-1625 DAILY DOSING PLUS PEGIFN-ALPHA 2A/RBV
✍ Scribed by Fabrycki, J.; Patel, D.; Yang, G.; Zhao, Y.; Podos, S.; Robison, H.; Robarge, L.; Olek, E.; Deshpande, M.; Huang, M.
- Book ID
- 122806548
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 58 KB
- Volume
- 56
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.